What is Ingevity Corporation share price today?

Ingevity Corporation (NGVT) share price today is {{live_price}}.

Can Indians buy Ingevity Corporation shares?

Yes, Indians can invest in the Ingevity Corporation (NGVT) from India. With INDmoney, you can buy Ingevity Corporation at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Ingevity Corporation at zero transaction cost.

How can I buy Ingevity Corporation shares from India?

It is very easy to buy Ingevity Corporation from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ingevity Corporation be purchased?

Yes, you can buy fractional shares of Ingevity Corporation with INDmoney app.

What are the documents required to start investing in Ingevity Corporation stocks?

To start investing in Ingevity Corporation, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ingevity Corporation

Today’s highest price of Ingevity Corporation (NGVT) is {{1_rba_end}}. Today’s lowest price of Ingevity Corporation (NGVT) is {{1_rba_st}}.

What is today's market capitalisation of Ingevity Corporation

Today's market capitalisation of Ingevity Corporation NGVT is 1.8B

What is the 52 Week High and Low Range of Ingevity Corporation

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Ingevity Corporation is down from its 52 Week High?

Ingevity Corporation (NGVT) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Ingevity Corporation is up from its 52 Week low?

Ingevity Corporation (NGVT) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Ingevity Corporation?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Ingevity Corporation

Mr. John C. Fortson is the current Chief Executive Officer (CEO) of Ingevity Corporation.

Home

US Stocks

Ingevity Corporation

Ingevity Corporation (NGVT)

$49.86

-0.24

(-0.48%)▲

Market is closed - opens 7 PM, 30 May 2023

Insights on Ingevity Corporation

Increasing Revenue
Revenue is up for the last 2 quarters, 383.6M → 392.6M (in $), with an average increase of 2.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 15.6M → 50.7M (in $), with an average increase of 69.2% per quarter
Vs APD
In the last 1 year, Air Products & Chemicals Inc. has given 9.2% return, outperforming this stock by 38.2%
Vs LIN
In the last 3 years, Linde Plc has given 13.3% return, outperforming this stock by 18.6%

Performance

$49.55
$50.54
$49.86
0.62%
Downside
Day's Volatility :1.96%
Upside
1.35%
$49.29
$90.81
$49.86
1.14%
Downside
52 Weeks Volatility :45.72%
Upside
45.09%

Returns

Period	Ingevity Corporation	Sector (Materials)	Index (Russel 2000)
3 Months	-39.61%	-6.8%	-6.7%
6 Months	-34.27%	-5.6%	-3.7%
1 Year	-28.44%	-12.7%	-6.3%
3 Years	-5.34%	37.5%	26.9%

Highlights

Market Capitalization	1.8B
Book Value	$19.62
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	5.18
PE Ratio	9.72
PEG Ratio	2.05
Wall Street Target Price	75.43

Profit Margin	12.01%
Operating Margin TTM	19.31%

Return On Assets TTM	7.75%
Return On Equity TTM	28.55%

Revenue TTM	1.7B
Revenue Per Share TTM	44.49
Quarterly Revenue Growth YOY	2.6%
Gross Profit TTM	570.1M
EBITDA	436.8M
Diluted Eps TTM	5.18
Quarterly Earnings Growth YOY	-0.13

EPS Estimate Current Year	5.45
EPS Estimate Next Year	6.59
EPS Estimate Current Quarter	1.13
EPS Estimate Next Quarter	1.94

Analyst Recommendation

Buy

76%Buy

23%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Ingevity Corporation(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 51.28%

Current $49.86

Target $75.43

Company Financials

	FY17	Y/Y Change
Revenue	972.4M	↑ 7.06%
Net Income	126.5M	↑ 259.38%
Net Profit Margin	13.01%	↑ 9.13%

	FY18	Y/Y Change
Revenue	1.1B	↑ 16.58%
Net Income	169.1M	↑ 33.68%
Net Profit Margin	14.92%	↑ 1.91%

	FY19	Y/Y Change
Revenue	1.3B	↑ 14.05%
Net Income	183.7M	↑ 8.63%
Net Profit Margin	14.21%	↓ 0.71%

	FY20	Y/Y Change
Revenue	1.2B	↓ 5.94%
Net Income	181.4M	↓ 1.25%
Net Profit Margin	14.92%	↑ 0.71%

	FY21	Y/Y Change
Revenue	1.4B	↑ 14.42%
Net Income	118.1M	↓ 34.9%
Net Profit Margin	8.49%	↓ 6.43%

	FY22	Y/Y Change
Revenue	1.7B	↑ 19.89%
Net Income	211.6M	↑ 79.17%
Net Profit Margin	12.68%	↑ 4.19%

	Q4 FY21	Q/Q Change
Revenue	336.0M	↓ 10.83%
Net Income	29.3M	↓ 797.62%
Net Profit Margin	8.72%	↑ 9.83%

	Q1 FY22	Q/Q Change
Revenue	382.8M	↑ 13.93%
Net Income	60.8M	↑ 107.51%
Net Profit Margin	15.88%	↑ 7.16%

	Q2 FY22	Q/Q Change
Revenue	419.9M	↑ 9.69%
Net Income	59.8M	↓ 1.64%
Net Profit Margin	14.24%	↓ 1.64%

	Q3 FY22	Q/Q Change
Revenue	482.0M	↑ 14.79%
Net Income	75.4M	↑ 26.09%
Net Profit Margin	15.64%	↑ 1.4%

	Q4 FY22	Q/Q Change
Revenue	383.6M	↓ 20.41%
Net Income	15.6M	↓ 79.31%
Net Profit Margin	4.07%	↓ 11.57%

	Q1 FY23	Q/Q Change
Revenue	392.6M	↑ 2.35%
Net Income	50.7M	↑ 225.0%
Net Profit Margin	12.91%	↑ 8.84%

	FY17	Y/Y Change
Total Assets	929.6M	↑ 11.62%
Total Liabilities	651.7M	↓ 6.66%

	FY18	Y/Y Change
Total Assets	1.3B	↑ 41.48%
Total Liabilities	976.5M	↑ 49.84%

	FY19	Y/Y Change
Total Assets	2.1B	↑ 62.84%
Total Liabilities	1.6B	↑ 64.97%

	FY20	Y/Y Change
Total Assets	2.3B	↑ 9.0%
Total Liabilities	1.7B	↑ 5.06%

	FY21	Y/Y Change
Total Assets	2.5B	↑ 5.76%
Total Liabilities	1.8B	↑ 6.07%

	FY22	Y/Y Change
Total Assets	2.7B	↑ 10.83%
Total Liabilities	2.0B	↑ 13.54%

	Q4 FY21	Q/Q Change
Total Assets	2.5B	↑ 1.76%
Total Liabilities	1.8B	↑ 0.76%

	Q1 FY22	Q/Q Change
Total Assets	2.5B	↓ 0.53%
Total Liabilities	1.8B	↓ 1.42%

	Q2 FY22	Q/Q Change
Total Assets	2.4B	↓ 3.66%
Total Liabilities	1.7B	↓ 3.28%

	Q3 FY22	Q/Q Change
Total Assets	2.3B	↓ 1.29%
Total Liabilities	1.7B	↓ 0.6%

	Q4 FY22	Q/Q Change
Total Assets	2.7B	↑ 17.17%
Total Liabilities	2.0B	↑ 19.79%

	FY17	Y/Y Change
Operating Cash Flow	174.3M	↑ 36.28%
Investing Cash Flow	-58.6M	↓ 53.64%
Financing Cash Flow	-57.8M	↑ 1600.0%

	FY18	Y/Y Change
Operating Cash Flow	252.0M	↑ 44.58%
Investing Cash Flow	-414.4M	↑ 607.17%
Financing Cash Flow	153.7M	↓ 365.92%

	FY19	Y/Y Change
Operating Cash Flow	275.7M	↑ 9.4%
Investing Cash Flow	-658.3M	↑ 58.86%
Financing Cash Flow	369.2M	↑ 140.21%

	FY20	Y/Y Change
Operating Cash Flow	352.4M	↑ 27.82%
Investing Cash Flow	-110.6M	↓ 83.2%
Financing Cash Flow	-50.2M	↓ 113.6%

	FY21	Y/Y Change
Operating Cash Flow	293.0M	↓ 16.86%
Investing Cash Flow	-140.6M	↑ 27.12%
Financing Cash Flow	-133.1M	↑ 165.14%

	Q4 FY21	Q/Q Change
Operating Cash Flow	76.0M	↓ 24.08%
Investing Cash Flow	-57.2M	↑ 118.32%
Financing Cash Flow	-12.8M	↓ 65.12%

	Q1 FY22	Q/Q Change
Operating Cash Flow	24.3M	↓ 68.03%
Investing Cash Flow	-30.2M	↓ 47.2%
Financing Cash Flow	-46.3M	↑ 261.72%

	Q2 FY22	Q/Q Change
Operating Cash Flow	90.5M	↑ 272.43%
Investing Cash Flow	-28.4M	↓ 5.96%
Financing Cash Flow	-147.0M	↑ 217.49%

	Q3 FY22	Q/Q Change
Operating Cash Flow	100.1M	↑ 10.61%
Investing Cash Flow	-86.1M	↑ 203.17%
Financing Cash Flow	-71.6M	↓ 51.29%

	Q1 FY23	Q/Q Change
Operating Cash Flow	5.2M	↓ 94.7%
Investing Cash Flow	1.9M	-
Financing Cash Flow	-5.6M	↓ 101.79%

Technicals Summary

Sell

Neutral

Buy

Ingevity Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Ingevity Corporation	-30.35%	-34.27%	-28.44%	-5.34%	-35.36%
PPG Industries Inc.	-4.31%	1.44%	5.72%	31.53%	32.35%
Air Products & Chemicals Inc.	-7.55%	-9.38%	11.24%	13.32%	69.24%
Linde plc	-4.32%	7.3%	9.71%	76.05%	115.27%
Sherwin-Williams Company, The	-1.21%	-5.15%	-14.51%	15.76%	77.18%
Ecolab Inc.	-1.11%	15.18%	1.83%	-21.48%	17.75%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Ingevity Corporation	9.72	9.72	2.05	5.45	0.29	0.08	0.0	19.62
PPG Industries Inc.	21.49	21.49	1.87	7.23	19.07	0.05	0.02	30.34
Air Products & Chemicals Inc.	28.2	28.2	1.92	11.42	0.15	0.06	0.03	63.29
Linde plc	39.71	39.71	2.73	13.78	0.11	0.05	0.01	81.53
Sherwin-Williams Company, The	28.07	28.07	2.05	8.72	0.79	0.09	0.01	12.34
Ecolab Inc.	41.37	41.37	2.01	4.99	0.16	0.06	0.01	25.79

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Ingevity Corporation	Buy	$1.8B	-35.36%	9.72	12.01%
PPG Industries Inc.	Buy	$31.3B	32.35%	21.49	7.18%
Air Products & Chemicals Inc.	Buy	$60.8B	69.24%	28.2	16.58%
Linde plc	Buy	$174.6B	115.27%	39.71	13.46%
Sherwin-Williams Company, The	Buy	$59.0B	77.18%	28.07	9.41%
Ecolab Inc.	Hold	$47.5B	17.75%	41.37	7.96%

Institutional Holdings

BlackRock Inc
12.35%
Vanguard Group Inc
10.21%
Inclusive Capital Partners LP
5.82%
LSV Asset Management
4.10%
State Street Corporation
3.27%
Thrivent Financial For Lutherans
2.79%

Organization	Ingevity Corporation
Employees	2050
CEO	Mr. John C. Fortson
Industry	Chemicals: Major Diversified

Ingevity Corporation (NGVT)

Insights on Ingevity Corporation

Increasing Revenue

Increasing Net Profit

Vs APD

Vs LIN